Medical News

RSS

Interim trading update for third quarter of 2009 from Q-Med

In order to ensure that shareholders have up to date information, Q-Med (STO:QMED) has deemed it appropriate to provide an interim trading update for the third quarter of 2009. However, it should be noted that there remains a high degree of uncertainty given the current economic environment.

18 Sep 2009

Top official calls for quicker, improved response to military mental health needs

The Associated Press: "Adm. Mike Mullen, chairman of the Joint Chiefs of Staff, expressed frustration Wednesday with the pace of government work to heal the mental wounds of war. ... 'Shame on us if we don't figure it out this time around to make sure that doesn't happen,' Mullen said at a defense forum on the nonphysical injuries of war in Alexandria, Va., just outside of Washington.

18 Sep 2009

InSight's fourth quarter 2009 revenues decreases by 17.3% year-on-year

InSight Health Services Holdings Corp. (“InSight”) (OTCBB: ISGT) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2009.

18 Sep 2009

Researchers to develop a safer and synthetic alternative to current heparin

With a $4.6 million grant from the National Institutes of Health (under the Bioengineering Research Partnership program), research led by Rensselaer Polytechnic Institute will make its important final steps toward the development of a safer, synthetic alternative to current heparin. The researchers believe that kilogram quantities of the new drug could be developed in under five years.

18 Sep 2009

Metabolic Research to participate in the Olympia Expo

Metabolic Research, Inc., makers of Stemulite, will have a booth in the Olympia Expo at the Las Vegas Convention Center South Hall, September 25th and 26th. The Stemulite booth will feature Corey and Paul Simpson, well-known super athlete trainers joined by Cristi Cuellar, Miss Bikini Mexico International Elite Champion.

18 Sep 2009

Nasdaq Stock Market issues deficiency letter to Neurobiological Technologies

Neurobiological Technologies, Inc. (Nasdaq: NTII) ("NTI") announced today that, on September 15, 2009, it received a letter from The Nasdaq Stock Market indicating that the bid price of NTI's common stock has closed below $1.00 per share for 30 consecutive business days.

18 Sep 2009

Study to determine the expression of S100A2 and p63 genes

As a member of the S100 family, S100A2 is considered a candidate tumor-suppressor gene. Recently, p63 gene, a new member of the p53 gene family, has been studied in the fields of tumorigenesis, cell apoptosis and tissue growth. At present, few studies have been carried out on the expression and relationship of S100A2 and p63 in EC.

18 Sep 2009

Pharmacyclics announces financial results for fourth quarter and FY 2009

Pharmacyclics, Inc. today reported financial results for its fourth quarter and fiscal year ended June 30, 2009. During the fourth quarter of fiscal 2009 Pharmacyclics incurred a GAAP net loss of $5.4 million, or $0.20 per share, compared to a net loss of $4.6 million, or $0.18 per share for the fourth quarter of fiscal 2008.

18 Sep 2009

Six former GRH patients to receive courage awards

The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.

18 Sep 2009

VA warns veterans not to disclose personal information over telephone

The Department of Veterans Affairs (VA) is warning Veterans not to give credit card numbers over the phone to callers claiming to update VA prescription information.

18 Sep 2009

Researchers study the role of stem cells in development of liver cancer

Penn State College of Medicine researchers, in collaboration with colleagues at the University of Southern California, have taken an important step in understanding the role of stem cells in development of liver cancer.

18 Sep 2009

AstraZeneca US President Rich Fante accepts Freedom Award

AstraZeneca (NYSE: AZN) accepted the 2009 Secretary of Defense Employer Support Freedom Award on Thursday at a ceremony in Washington, D.C. This award is the highest recognition given by the U.S. government to employers for their outstanding support of employees who serve in the National Guard and Reserve.

18 Sep 2009

MemoryXL improves cognitive performance in Alzheimer's disease

Thomas Shea, Ph.D, and his team of scientists, tested the effects of MemoryXL previously shown to improve cognitive performance in Alzheimer's disease on adults without dementia.

18 Sep 2009

White House says Baucus' 'building block' is not the end of the debate

President Barack Obama's spokesman, Robert Gibbs, called the health care reform plan released Wednesday by Senate Finance Committee Chairman Max Baucus "an important building block" that "gets us closer to comprehensive health care reform" Roll Call reports.

18 Sep 2009

Results from the BLOSSOM trial announced by Arena Pharmaceuticals

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported today positive, highly significant top-line results from the BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) trial.

18 Sep 2009

With Baucus Bill no longer a mystery, party leaders contemplate strategy

Now that the long-awaited Baucus health overhaul is out, Democratic leaders are pondering how they will collect the votes and support necessary to move a bill through Congress.

18 Sep 2009

UHC's Clinical Documentation Audit Profile assists hospitals with RAC reviews

University HealthSystem Consortium (UHC) has announced the development of the Clinical Documentation Audit Profile, designed to assist hospitals with Recovery Audit Contractor (RAC) reviews.

18 Sep 2009

New vaccine may prove effective against urinary tract infections

University of Michigan scientists have made an important step toward what could become the first effective vaccine to prevent urinary tract infections, if the robust immunity achieved in mice can be reproduced in humans.

18 Sep 2009

Study reveals microRNAs affect tumor progression

UCSF researchers have identified collections of tiny molecules known as microRNAs that affect distinct processes critical for the progression of cancer. The findings, they say, expand researchers' understanding of the important regulatory function of microRNAs in tumor biology and point to new directions for future study and potential treatments.

18 Sep 2009

Results of American Medical Systems Holdings' exchange offer announced

American Medical Systems Holdings, Inc. (NASDAQ: AMMD) (the “Company”), today announced the results of its exchange offer (the “Exchange Offer”) in which the Company offered $1,000 principal amount of its newly issued 4.00% Convertible Senior Subordinated Notes due 2041 (the “2041 Notes”) in exchange for each $1,000 principal amount of its outstanding 3.25% Convertible Senior Subordinated Notes due 2036 (the “2036 Notes”), for up to $250 million, and no less than $100 million, aggregate principal amount of 2036 Notes.

18 Sep 2009